Stock DNA
Pharmaceuticals & Biotechnology
JPY 116,824 Million (Small Cap)
18.00
NA
0.00%
-0.14
9.16%
1.55
Revenue and Profits:
Net Sales:
57,887 Million
(Quarterly Results - Jun 2025)
Net Profit:
4,919 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.91%
0%
-4.91%
6 Months
3.6%
0%
3.6%
1 Year
-9.37%
0%
-9.37%
2 Years
8.76%
0%
8.76%
3 Years
-4.01%
0%
-4.01%
4 Years
-20.41%
0%
-20.41%
5 Years
-15.89%
0%
-15.89%
Earth Corp. for the last several years.
Risk Adjusted Returns v/s 
News

Earth Corp. Experiences Valuation Shift Amidst Changing Market Sentiment and Metrics
Earth Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its evaluation. This adjustment reflects shifts in valuation metrics and technical indicators, suggesting a new perspective on its financial standing and market sentiment as it navigates its position in the industry.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.11%
EBIT Growth (5y)
0.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.07
Tax Ratio
32.59%
Dividend Payout Ratio
75.82%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.30%
ROE (avg)
10.16%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.56
EV to EBIT
14.20
EV to EBITDA
8.91
EV to Capital Employed
1.56
EV to Sales
0.64
PEG Ratio
0.37
Dividend Yield
NA
ROCE (Latest)
10.96%
ROE (Latest)
8.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
57,887.00
55,046.00
5.16%
Operating Profit (PBDIT) excl Other Income
8,427.00
6,935.00
21.51%
Interest
27.00
15.00
80.00%
Exceptional Items
-302.00
-15.00
-1,913.33%
Consolidate Net Profit
4,919.00
4,288.00
14.72%
Operating Profit Margin (Excl OI)
125.80%
105.00%
2.08%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 5.16% vs 11.18% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 14.72% vs 30.73% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
169,278.00
158,344.00
6.91%
Operating Profit (PBDIT) excl Other Income
10,996.00
10,608.00
3.66%
Interest
38.00
33.00
15.15%
Exceptional Items
-1,374.00
0.00
Consolidate Net Profit
3,792.00
4,410.00
-14.01%
Operating Profit Margin (Excl OI)
38.00%
40.20%
-0.22%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 6.91% vs 3.94% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -14.01% vs -21.79% in Dec 2023
About Earth Corp. 
Earth Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






